[Qualification of patients with angina pectoris for beta-adrenolytic drug treatment].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000166:cytology; D010101:Oxygen Consumption / Q000187:drug effects; D010146:Pain / Q000188:drug therapy; D005082:Physical Exertion; D011433:Propranolol / Q000627:therapeutic use; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D011433:Propranolol
Niektóre problemy zwiázane z kwalifikowaniem chorych z dławica piersiowa do leczenia lekami beta-adrenolitycznymi